Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer

Neoadjuvant chemoradiotherapy (CRT) has been proven to increase local control in rectal cancer, but the optimal interval between CRT and surgery is still unclear. The purpose of this study was to analyse the influence of variations in clinical practice regarding timing of surgery on pathological response at a population level.

[1]  N. Shepherd,et al.  International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systems. , 2012, Human pathology.

[2]  R. Glynne-Jones,et al.  Critical appraisal of the ‘wait and see’ approach in rectal cancer for clinical complete responders after chemoradiation , 2012, The British journal of surgery.

[3]  H. Heneghan,et al.  Systematic review and meta‐analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer , 2012, The British journal of surgery.

[4]  A. Rosman,et al.  Complete Pathologic Response after Combined Modality Treatment for Rectal Cancer and Long-Term Survival: A Meta-Analysis , 2012, Annals of Surgical Oncology.

[5]  L. Boni,et al.  Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  David D. Smith,et al.  Optimal Timing of Surgery After Chemoradiation for Advanced Rectal Cancer: Preliminary Results of a Multicenter, Nonrandomized Phase II Prospective Trial , 2011, Annals of surgery.

[7]  K. Haustermans,et al.  Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study , 2011, Annals of Surgical Oncology.

[8]  Y. Chua.  Pathological complete response: still a relevant endpoint in rectal cancer? , 2010, The Lancet. Oncology.

[9]  V. Fazio,et al.  Predictive Factors of Pathologic Complete Response After Neoadjuvant Chemoradiation for Rectal Cancer , 2009, Annals of surgery.

[10]  A. Bateman,et al.  Rectal cancer staging post neoadjuvant therapy – how should the changes be assessed? , 2009, Histopathology.

[11]  A. Zaitoun,et al.  Regression of rectal cancer with radiotherapy with or without concurrent capecitabine--optimising the timing of surgical resection. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

[12]  R. Glynne-Jones,et al.  Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis , 2008, The British journal of surgery.

[13]  Seung-Yong Jeong,et al.  Optimal Surgery Time After Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancers , 2008, Annals of surgery.

[14]  A. Figer,et al.  An Interval >7 Weeks between Neoadjuvant Therapy and Surgery Improves Pathologic Complete Response and Disease–Free Survival in Patients with Locally Advanced Rectal Cancer , 2008, Annals of Surgical Oncology.

[15]  T. Junginger,et al.  Neoadjuvant Chemoradiation and Local Excision for T2-3 Rectal Cancer , 2008, Annals of Surgical Oncology.

[16]  E. Rosato,et al.  Effect of time interval between surgery and preoperative chemoradiotherapy with 5‐fluorouracil or 5‐fluorouracil and oxaliplatin on outcomes in rectal cancer , 2007, Journal of surgical oncology.

[17]  M. Stamos,et al.  Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancer. , 2006, American journal of surgery.

[18]  P. Morel,et al.  Lymph node retrieval in abdominoperineal surgical specimen is radiation time-dependent , 2006, World journal of surgical oncology.

[19]  W. Hohenberger,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[20]  J. Guillem,et al.  Rate of Pathologic Complete Response With Increased Interval Between Preoperative Combined Modality Therapy and Rectal Cancer Resection , 2004, Diseases of the colon and rectum.

[21]  David E. Stein,et al.  Longer Time Interval Between Completion of Neoadjuvant Chemoradiation and Surgical Resection Does Not Improve Downstaging of Rectal Carcinoma , 2003, Diseases of the colon and rectum.

[22]  J. Douillard,et al.  Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer. , 2001, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[23]  P. Adeleine,et al.  Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  O. C. S. Mrcs,et al.  MRI Predictive Factors for Long-Term Outcomes of Low Rectal Tumours , 2011, Annals of Surgical Oncology.

[25]  C. Penna.  [Neoadjuvant therapy for rectal cancer]. , 2006, Gastroenterologie clinique et biologique.